How can the $23B market for PD-1 blockers grow? ‘Pan-adjuvant’ use is key: report arlene.weintraub Thu, 12/03/2020 – 09:09 More: How can the B market for PD-1 blockers grow? 'Pan-adjuvant' use is key: report Source: fierce
read moreJSR’s CDMO arm plans $150M biologics facility in Research Triangle alongside unnamed pharma partner kblankenship Thu, 12/03/2020 – 09:01 More: JSR's CDMO arm plans 0M biologics facility in Research Triangle alongside unnamed pharma partner Source: fierce
read moreTherapy targets CD59 protein to preserve vision in geographical atrophy patients More: Janssen buys rights to Hemera’s eye disease gene therapy candidate Source: News
read morePartnership will seek to develop small molecules for oncology/immunology targets More: AbbVie partners with Frontier Medicines on protein degrader development Source: News
read moreDrug Safety Research Unit set to conduct active surveillance study on COVID-19 vaccines More: DSRU plans ‘post-authorisation’ study of COVID-19 vaccines in the UK Source: News
read morePlatform will enable Bayer to pursue external collaborations and bolster internal capabilities More: Bayer establishes new cell and gene therapy platform Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals